Short Interest in ENDRA Life Sciences Inc. (NASDAQ:NDRA) Decreases By 24.5%

ENDRA Life Sciences Inc. (NASDAQ:NDRA) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 39,400 shares, a decrease of 24.5% from the December 31st total of 52,200 shares. Based on an average daily volume of 260,700 shares, the days-to-cover ratio is currently 0.2 days. Approximately 7.3% of the company’s stock are short sold.

ENDRA Life Sciences Price Performance

NDRA opened at $5.20 on Friday. The business’s 50-day moving average is $5.56 and its two-hundred day moving average is $1,104.04. ENDRA Life Sciences has a 1 year low of $4.01 and a 1 year high of $2,240.00. The firm has a market capitalization of $2.81 million, a PE ratio of -0.01 and a beta of 0.52.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.